Holen Sie sich die Stockscreener-App
0.3493
5.05%
0.0168
Handel nachbörslich:
.34
-0.0093
-2.66%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Prophase Labs Inc Aktie (PRPH) Neueste Nachrichten
ProPhase Labs Inc (PRPH) Q2 2025 Earnings Call Highlights: Strategic Moves and Future Prospects - Yahoo Finance
Prophase Labs, Inc. shares fall 8.11% premarket as federal budget cuts and VC funding into oncology ventures. - AInvest
ProPhase Labs Achieves Key U.S. Patent for Test - MSN
Why did PRPH's Q4 2024 earnings surprise analysts? - AInvest
Volume Surge May Signal Institutional Interest in ProPhase Labs Inc.Trade Risk Assessment & Free AI Powered Buy and Sell Recommendations - sundaytimes.kr
Can ProPhase Labs Inc. deliver alphaCPI Data & Precise Swing Trade Alerts - thegnnews.com
Price Channel Expanding on ProPhase Labs Inc.’s ChartTrade Ideas & Daily Entry Point Trade Alerts - beatles.ru
Prophase Labs shares rise 2.14% intraday after earnings results presentation. - AInvest
ProPhase Labs 2025 Q2 Earnings Improved Losses Despite Revenue Decline - AInvest
ProPhase Labs Reports Turnaround and Strategic Growth - TipRanks
ProPhase Labs Q2 2025 Earnings Call Transcript - MarketBeat
ProPhase Labs' Q2 2025: Unraveling Contradictions in Cancer Test Strategies and Crypto Investments - AInvest
ProPhase Labs, Inc. SEC 10-Q Report - TradingView
Transcript : ProPhase Labs, Inc., Q2 2025 Earnings Call, Aug 13, 2025 - MarketScreener
Earnings call transcript: ProPhase Labs Q2 2025 reveals EPS beat, stock drops - Investing.com
ProPhase Labs Inc. To Present Second Quarter 2025 Financial Results On August 13, 2025 - Barchart.com
ProPhase Labs, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2025 - MarketScreener
ProPhase Labs earnings beat by $0.04, revenue fell short of estimates - Investing.com Canada
ProPhase Labs Inc Reports Q2 2025 Earnings: EPS of $(0.11) Misses Estimate, Revenue Falls Short at $1.2 Million - GuruFocus
ProPhase Labs Posts Narrower Q2 Loss - The Motley Fool
ProPhase Labs Posts Narrower Q2 Loss - Nasdaq
ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025 | PRPH Stock News - GuruFocus
Can ProPhase Labs Inc. expand into new marketsJuly 2025 Macro Moves & Real-Time Volume Surge Alerts - newsyoung.net
ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025 - GlobeNewswire
ProPhase Labs shares fall 1.13% premarket after receiving USPTO approval for biomarker-driven systems. - AInvest
ProPhase Labs Schedules Q2 2025 Earnings Release and Conference Call - AInvest
ProPhase Labs Earnings Preview: Analysts Expect $-0.15 EPS, Shares Down 85.7% Over the Last Year - AInvest
What caused PRPH's earnings to drop in Q3 2024? - AInvest
How did PRPH's 2024 earnings trend evolve? - AInvest
What does PRPH's earnings volatility indicate? - AInvest
ProPhase Labs Seeks Enhanced Shareholder Value through Reverse Merger and Bitcoin Integration - AInvest
ProPhase Labs (PRPH.O) Surges Over 33% — What’s Behind the Sharp Intraday Move? - AInvest
PRPH.O Surges 29.75%: Tracing the Source of the Sudden Intraday Spike - AInvest
ProPhase Labs Surges 23.75%: Patent Grant and Earnings Call Spark Volatility - AInvest
ProPhase Labs (PRPH) Surges 27.76% on Patent Approval and BE-Smart Validation—What’s Next for This Biotech Play? - AInvest
ProPhase Labs stock soars after securing patent for esophageal disease test By Investing.com - Investing.com South Africa
ProPhase Labs stock soars after securing patent for esophageal disease test - Investing.com
ProPhase Labs shares rise 35.82% premarket after receiving US patent for esophageal product. - AInvest
ProPhase Labs Gets US Patent For Esophageal Adenocarcinoma Risk Assessment; Shares Up Pre-Bell - MarketScreener
ProPhase Labs receives patent for Barrett’s esophagus testing technology - Investing.com
ProPhase Labs Announces Full USPTO Approval for Issuance of - GlobeNewswire
ProPhase Labs Secures Game-Changing Patent for Early Cancer Detection with 95% Accuracy Rate - Stock Titan
ProPhase Labs announces closing of $3M senior secured convertible notes - MSN
ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025 - GlobeNewswire
ProPhase Labs to present Q2 2025 financial results on virtual conference call. - AInvest
ProPhase Labs Earnings: Biotech Leader Sets Q2 Financial Results Presentation This Week - Stock Titan
ProPhase Labs PRPH 2025Q2 Earnings Preview Neutral Outlook Amid Uncertain Market Conditions - AInvest
Is ProPhase Labs Inc. vulnerable to short sellersElite Return Strategy Watch - thegnnews.com
Prophase Labs Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView
ProPhase Labs Inc. Bounces Off Moving Average SupportLow Drawdown Real Time Trading Tips Shared - beatles.ru
ProPhase Labs Appoints New Fractional CFO - TipRanks
ProPhase Labs, Inc. Appoints Steven M. Plumb as Fractional Chief Financial Officer, Effective August 6, 2025 - MarketScreener
Sector ETF Data Correlates with Strength in ProPhase Labs Inc.Low Volatility Stable Growth Picks Rank High - metal.it
Is This a Bottoming Phase for ProPhase Labs Inc.Confirmed Setup With Expert Accuracy Supported - beatles.ru
ProPhase Labs Inc. Rebound Backed by Sentiment ShiftInvestment Plan With Growth Optimization Finalized - metal.it
Why is ProPhase Labs Inc. stock attracting strong analyst attentionBreakneck growth rates - Jammu Links News
How does ProPhase Labs Inc. generate profit in a changing economyExceptional trading performance - Jammu Links News
Is ProPhase Labs Inc. a growth stock or a value stockMaximize your portfolio’s earning power - Jammu Links News
What makes ProPhase Labs Inc. stock price move sharplyHigh-yield trading alerts - Jammu Links News
Is ProPhase Labs Inc. a good long term investmentTrack high-yield stocks before they peak - Jammu Links News
What institutional investors are buying ProPhase Labs Inc. stockInvest confidently with data-driven strategies - Jammu Links News
Should I hold or sell ProPhase Labs Inc. stock in 2025Consistently profitable trades - Jammu Links News
How volatile is ProPhase Labs Inc. stock compared to the marketBuild a diversified portfolio for risk management - Jammu Links News
What drives ProPhase Labs Inc. stock priceOver 200% growth - Jammu Links News
What are analysts’ price targets for ProPhase Labs Inc. in the next 12 monthsBuild a winning investment strategy - Jammu Links News
0.67%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):